“The cardiovascular effects of EtOH were significantly attenuated by ICV or by RVLM post treatment with ketamine (an NMDA receptor antagonist), N5-(nitroamidino)-L-2,5-diaminopentanoic acid ( L-NNA ; a NO synthase inhibitor), or bicuculline (a GABA receptor antagonist).”